KalshiScience and Technology
Will the FDA approve retatrutide?
retatrutide (LY3437943)
Ends Jan 1, 2027
Bet NowDisclosure
18+ only. Event contracts carry significant risk and are not suitable for everyone, you can lose the entire amount you commit. Not available in all jurisdictions; restrictions and eligibility requirements apply.
- Before Jan 1, 202723.4K VOL.——
- Before Jul 1, 202710.1K VOL.——
- Before Jan 1, 20281.5K VOL.——
- Before Jul 1, 202844.4 VOL.——
- Before Jan 1, 202974.7 VOL.——
Rules Summary
If the FDA approves retatrutide (LY3437943) for marketing before Jan 1, 2027, then the market resolves to Yes.
Timeline and Payout
- Opened
- May 14, 2026, 2:00 AM
- Closes
- Jan 1, 2027, 4:59 AM
- Pays out
- 0.5 hours after close
Series KXFDARETATRUTIDE · Event KXFDARETATRUTIDE-RET · Market KXFDARETATRUTIDE-RET-27JAN01